Pharmaceutical Processing |
Alvotech Invests $250M in Biopharmaceuticals
Pharmaceutical Processing Alvotech today announced plans to invest $250 million in the development and manufacturing of a portfolio of biosimilar monoclonal antibodies. Alvotech’s current biosimilar assets include follow-on versions of leading monoclonal antibodies molecules … Alvogen Pumping $250M into Developing Biosimilars, with New Iceland PlantGenetic Engineering News Alvotech Invests $250 Million in BiopharmaceuticalsPharmiWeb.com (press release) |
Holidays a great time to discuss organ donation: Laureen Harper – CTV News
The Globe and Mail |
Holidays a great time to discuss organ donation: Laureen Harper
CTV News “This holiday season we were hoping to get people talking and going to the websites and signing up to be an organ donor,” Harper told CTV’s Canada AM Thursday from Ottawa. “But more importantly, this is a time of year when you are with our family, so … Ensuring that organ donation wishes are honoredNorthShoreOfLongIsland.com Canada’s donor drought: why some are looking to social media for a new kidneyThe Globe and Mail Minister Ambrose Launches Organ and Tissue Donor Social Media CampaignEIN News (press release) |
Dubai launches campaign to raise awareness of heart failure – The National
|
Dubai launches campaign to raise awareness of heart failure
The National “Heart failure develops over time as the pumping action of the heart gets weaker,” said Dr Arif Al Mulla, head of cardiology at Dubai Hospital. “It can affect either the right, the left, or both sides of the heart. People with heart problems, those who … Heart failure awareness drive launched in DubaiEmirates 24/7 youth facing higher risk of heart diseasegulfnews.com |
Alvotech to invests $250M in the development of biosimilar monoclonal antibodies – News-Medical.net
Pharmaceutical Processing |
Alvotech to invests $250M in the development of biosimilar monoclonal antibodies
News-Medical.net Alvotech, a powerful new player in the field of biopharmaceuticals, today announced plans to invest $250 million in the development and manufacturing of a portfolio of biosimilar monoclonal antibodies. Alvotech’s current biosimilar assets include … Alvotech Invests $250 Million in BiopharmaceuticalsBusiness Wire (press release) Alvotech Invests $250M in BiopharmaceuticalsPharmaceutical Processing Alvogen Pumping $250M into Developing Biosimilars, with New Iceland PlantGenetic Engineering News |
The Unbelievable Truth: can you sort fact from fiction? – Telegraph.co.uk
The Unbelievable Truth: can you sort fact from fiction?Telegraph.co.ukNelson was a sickly person, and it is thought that he was left with incurable sea sickness and recurrent partial paralysis following a bout of malaria whilst on a voyage to India. Hi…
Go Guide for Dec. 5-11 – Ocala
Go Guide for Dec. 5-11OcalaDonation of unwrapped toy or $5. Ride ends at the downtown square with live music from 2 to 6 p.m. (854-1190 or 732-2488). CANDLE LIGHTING: Compassionate Friends Worldwide Candle Lighting to honor and remember children who ha…
Donor dilemma divides doctors – Cyprus Mail
Donor dilemma divides doctorsCyprus MailDOCTORS need better education when it comes to the complicated ethical issue of brain death and when organs can be removed for life-saving transplants, stakeholders said at a public consultation organised by the …
Affordable drug for small cell lung cancer – Times of India
|
Affordable drug for small cell lung cancer
Times of India Dr T Ramasami, secretary to the Government of India, Department of Science and Technology said, “Lung cancer is a major killer among all cancers. In this scenario, the drug can be a new hope for the patients suffering form lung cancer, particularly for … |
Vitamin D deficiency linked with increasing heart diseases in India – Times of India
Vitamin D deficiency linked with increasing heart diseases in IndiaTimes of IndiaAbout 25% of deaths in the age group of 25-69 years occur because of heart diseases according to a recent study by the Registrar General of India (RGI) and the Indian Coun…
GPs sign up heart failure and hypertension patients for redundant remote … – Pulse
GPs sign up heart failure and hypertension patients for redundant remote …PulseExclusive Heart failure or hypertension are the main areas where GPs are recruiting patients for the remote monitoring DES this year – even though the enhanced service wil…